MedTrace Logo

Long Term Monitoring for Risk of Sudden Death

NCT04124237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1051

Last updated 2020-11-16

No results posted yet for this study

Summary

Risk prediction in in inherited heart rhythm conditions that may cause sudden cardiac arrest or death is difficult. Sometimes the risks may be low but the loss of life in an otherwise healthy young individual is catastrophic. Clinicians often treat to the extreme to prevent this and so often those at unknown risk for a serious cardiac event are treated with an implanted cardioverter defibrillator (ICD) to protect against sudden death even though the risk is low or unknown. ICDs them selves are not without adverse events such as needing battery replacements, mechanical complications, inappropriate shocks and body image and self esteem issues for the patient. This study will use an inject able monitor that is less invasive to monitor inherited heart rhythm patients long term to help gather long term heart rhythm data (3 years) on patients with an inherited heart rhythm that will help to detect symptoms of dangerous heart rhythms so that the appropriate care can be provided.

Conditions

  • Inherited Cardiac Arrhythmias
  • Long QT Syndrome
  • Arrhythmogenic Right Ventricular Cardiomyopathy
  • Brugada Syndrome
  • Catecholaminergic Polymorphic Ventricular Tachycardia

Sponsors & Collaborators

  • Kingston Health Sciences Centre

    collaborator OTHER

  • Quebec Heart Institute

    collaborator OTHER

  • Montreal Heart Institute

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Andrew D Krahn, Dr. · University of British Columbia

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-15
Primary Completion
2020-08-30
Completion
2020-08-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124237 on ClinicalTrials.gov